Peak Wealth Management LLC
- SEC CIK
- 0002094948
- Latest filing
- Jul 14, 2026
The latest 13F from Peak Wealth Management LLC covers Q2 2026 (filed Jul 14, 2026): 59 long positions worth $142.5M. The top 10 holdings make up 64.1% of the portfolio, and the largest is Schwab U.S. Large-Cap Value ETF at 11.4%. Livermore has 3 filings on Form 13F from this institution, going back to Q4 2025.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 7
- Est. +$12.7M
- Added
- 24
- Est. +$8.81M
- Reduced
- 12
- Est. −$11.5M
- Sold out
- 2
- Est. −$3.13M
Top 5 holdings
Share of this quarter's portfolio value
- Schwab U.S. Large-Cap Value ETF80852440911.4%$16.2M
- Schwab U.S. Large-Cap Growth ETF80852430010.5%$14.9M
- BlackRock ETF Trust09290C1038.2%$11.6M
- Schwab International Equity ETF8085248056.1%$8.71M
- Vanguard Total Bond Market ETF9219378355.7%$8.18M
Biggest buys
New and added positions, by estimated amount bought
- BlackRock ETF Trust09290C855+$4.20MNew
- BlackRock ETF Trust09290C665+$3.70MNew
- BlackRock ETF Trust II092528835+$3.46MNew
- Schwab U.S. Large-Cap Value ETF808524409+$2.64MAdded
- Schwab U.S. Large-Cap Growth ETF808524300+$1.95MAdded
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- BlackRock ETF Trust09290C855+2.95 pp0.0% → 2.9%
- BlackRock ETF Trust09290C665+2.59 pp0.0% → 2.6%
- BlackRock ETF Trust II092528835+2.43 pp0.0% → 2.4%
- Schwab U.S. Large-Cap Value ETF808524409+1.62 pp9.8% → 11.4%
- Schwab U.S. Large-Cap Growth ETF808524300+1.31 pp9.2% → 10.5%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
- iShares MSCI USA Quality Factor ETF46432F339−$4.84MReduced
- iShares Tr46435G672−$2.92MSold out
- iShares Core MSCI Emerging Markets ETF46434G103−$2.73MReduced
- Schwab International Equity ETF808524805−$1.75MReduced
- BlackRock ETF Trust09290C780−$887.2KReduced
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
- iShares MSCI USA Quality Factor ETF46432F339−3.48 pp4.1% → 0.6%
- iShares Tr46435G672−2.40 pp2.4% → 0.0%
- iShares Core MSCI Emerging Markets ETF46434G103−1.83 pp5.7% → 3.9%
- Schwab International Equity ETF808524805−1.56 pp7.7% → 6.1%
- REGNRegeneron Pharmaceuticals, Inc.
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $142.5M
- +$20.6M (+16.9%) vs. prior quarter
- Positions
- 59
- +5 vs. prior quarter
- Top 10 concentration
- 64.1%
- Top 10 as share of value
- Turnover
- 11.1%
- Q2 2026, one quarter
- Average holding period
- 2.8 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2025), so positions held before then are understated.
13F filings by quarter
3 quarters, going back to Q4 2025. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $142.5M (Q2 2026)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 14, 2026 | 59 | $142.5M | Schwab U.S. Large-Cap Value ETFSchwab U.S. Large-Cap Growth ETFBlackRock ETF Trust | vs. Q1 2026 | SEC |
| Q1 2026 | Apr 14, 2026 | 54 | $121.9M | Schwab U.S. Large-Cap Value ETFSchwab U.S. Large-Cap Growth ETFBlackRock ETF Trust | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 4, 2026 | 51 | $119.6M | Schwab U.S. Large-Cap Growth ETFSchwab U.S. Large-Cap Value ETFBlackRock ETF Trust | – | SEC |